Jennii Luu

No ORCID on file · 2 papers in corpus · active 2023-2026

Study types

  • article 1
  • preprint 1

Condition tags

  • endometriosis 1
preprint 2026
Dienogest interrupts the chemokine signalling axis in endometriotic lesions with resistant signatures providing novel opportunities for personalised treatment.
·doi:10.21203/rs.3.rs-8096027/v1

Abstract Progestins are important first line and adjuvant medications for endometriosis, yet their efficacy varies among patients. Dienogest (DNG), a 4th generation progestin, is one of the most prescribed and successful progestins, althou…

article 2023
Using a Quantitative High-Throughput Screening Platform to Identify Molecular Targets and Compounds as Repurposing Candidates for Endometriosis
Biomolecules ·doi:10.3390/biom13060965

Endometriosis, defined as the growth of hormonally responsive endometrial-like tissue outside of the uterine cavity, is an estrogen-dependent, chronic, pro-inflammatory disease that affects up to 11.4% of women of reproductive age and gende…